Clinical Trial Update: Open-label, Multicenter Study Assessing Preference for Deferasirox Film-coated Tablet Compared to Dispersible Tablet [Phase 2]

View source ↗

Summary

Phase 2 open-label multicenter trial assessing patient preference for deferasirox film-coated tablet versus dispersible tablet in thalassemia; completed with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-transfusion-dependent Thalassemia
• Transfusion-dependent Thalassemia

Drugs mentioned

• Deferasirox Film-coated Tablet (deferasirox)
• Deferasirox dispersible tablet (deferasirox)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Transfusion-dependent Thalassemia, Non-transfusion-dependent Thalassemia | Phase 2 | Status: COMPLETED | Results posted: 2021-10-04